Venus Concept (VERO) Competitors $2.28 -0.05 (-2.15%) Closing price 04:00 PM EasternExtended Trading$2.31 +0.03 (+1.36%) As of 07:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VERO vs. MHUA, CODX, SINT, FEMY, LYRA, POAI, TNON, DHAI, STSS, and PAVMShould you be buying Venus Concept stock or one of its competitors? The main competitors of Venus Concept include Meihua International Medical Technologies (MHUA), Co-Diagnostics (CODX), Sintx Technologies (SINT), Femasys (FEMY), Lyra Therapeutics (LYRA), Predictive Oncology (POAI), Tenon Medical (TNON), DIH Holding US (DHAI), Sharps Technology (STSS), and PAVmed (PAVM). These companies are all part of the "medical equipment" industry. Venus Concept vs. Its Competitors Meihua International Medical Technologies Co-Diagnostics Sintx Technologies Femasys Lyra Therapeutics Predictive Oncology Tenon Medical DIH Holding US Sharps Technology PAVmed Venus Concept (NASDAQ:VERO) and Meihua International Medical Technologies (NASDAQ:MHUA) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, valuation, institutional ownership, earnings, analyst recommendations, risk, media sentiment and profitability. Do insiders & institutionals have more ownership in VERO or MHUA? 87.4% of Venus Concept shares are owned by institutional investors. Comparatively, 1.2% of Meihua International Medical Technologies shares are owned by institutional investors. 28.0% of Venus Concept shares are owned by company insiders. Comparatively, 66.6% of Meihua International Medical Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has stronger earnings and valuation, VERO or MHUA? Meihua International Medical Technologies has higher revenue and earnings than Venus Concept. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVenus Concept$64.83M0.05-$47M-$50.78-0.04Meihua International Medical Technologies$96.90M0.14$10.84MN/AN/A Which has more risk and volatility, VERO or MHUA? Venus Concept has a beta of 0.09, suggesting that its share price is 91% less volatile than the S&P 500. Comparatively, Meihua International Medical Technologies has a beta of 0.79, suggesting that its share price is 21% less volatile than the S&P 500. Is VERO or MHUA more profitable? Meihua International Medical Technologies has a net margin of 0.00% compared to Venus Concept's net margin of -68.77%. Meihua International Medical Technologies' return on equity of 0.00% beat Venus Concept's return on equity.Company Net Margins Return on Equity Return on Assets Venus Concept-68.77% -871.77% -61.92% Meihua International Medical Technologies N/A N/A N/A Does the media refer more to VERO or MHUA? In the previous week, Meihua International Medical Technologies had 1 more articles in the media than Venus Concept. MarketBeat recorded 2 mentions for Meihua International Medical Technologies and 1 mentions for Venus Concept. Meihua International Medical Technologies' average media sentiment score of 1.45 beat Venus Concept's score of 0.95 indicating that Meihua International Medical Technologies is being referred to more favorably in the news media. Company Overall Sentiment Venus Concept Positive Meihua International Medical Technologies Positive SummaryMeihua International Medical Technologies beats Venus Concept on 10 of the 11 factors compared between the two stocks. Get Venus Concept News Delivered to You Automatically Sign up to receive the latest news and ratings for VERO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VERO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VERO vs. The Competition Export to ExcelMetricVenus ConceptMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.24M$6.69B$5.74B$10.24BDividend YieldN/A1.20%5.69%4.59%P/E Ratio-0.0425.8474.9326.41Price / Sales0.05173.23457.2789.16Price / CashN/A22.1825.8129.91Price / Book0.534.9413.256.28Net Income-$47M$176.38M$3.29B$270.38M7 Day Performance1.33%4.95%0.47%2.70%1 Month Performance-1.72%6.43%4.60%5.99%1 Year Performance-61.97%10.59%73.42%25.94% Venus Concept Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VEROVenus Concept1.1075 of 5 stars$2.28-2.1%N/A-61.1%$3.24M$64.83M-0.04410MHUAMeihua International Medical Technologies1.6381 of 5 stars$0.39+3.4%N/A-54.8%$12.47M$96.90M0.00620Positive NewsShort Interest ↓Gap DownCODXCo-Diagnostics4.0593 of 5 stars$0.31+0.5%$5.50+1,662.8%-74.0%$12.02M$3.91M-0.27100Short Interest ↑Gap UpSINTSintx Technologies1.9717 of 5 stars$4.26-7.2%$28.00+557.3%+6.9%$11.84M$2.89M-0.0840Gap DownFEMYFemasys3.0932 of 5 stars$0.37-5.2%$7.33+1,909.1%-65.0%$11.79M$1.63M-0.4230Short Interest ↑Gap UpHigh Trading VolumeLYRALyra Therapeutics3.5297 of 5 stars$6.69+1.3%$100.00+1,395.9%-55.1%$10.97M$1.53M-0.2350Positive NewsGap UpPOAIPredictive Oncology1.2983 of 5 stars$0.98+2.2%N/A+5.6%$10.70M$1.66M-0.3230Positive NewsShort Interest ↓TNONTenon Medical2.1152 of 5 stars$1.15-1.7%$5.50+378.3%-84.2%$10.21M$3.28M-0.048Short Interest ↓DHAIDIH Holding US0.2845 of 5 stars$0.21-7.6%N/A-91.3%$9.75M$64.47M-0.69N/AShort Interest ↑STSSSharps Technology0.7458 of 5 stars$9.38-8.4%N/AN/A$9.61MN/A-0.013PAVMPAVmed4.2186 of 5 stars$0.43+1.0%$19.00+4,288.0%-76.4%$9.50M$2.99M0.3790News CoverageShort Interest ↑ Related Companies and Tools Related Companies MHUA Alternatives CODX Alternatives SINT Alternatives FEMY Alternatives LYRA Alternatives POAI Alternatives TNON Alternatives DHAI Alternatives STSS Alternatives PAVM Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VERO) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Venus Concept Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Venus Concept With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
